Cargando…

Gene expression profiling of Ewing sarcoma tumours reveals the prognostic importance of tumour–stromal interactions: a report from the Children's Oncology Group

Relapse of Ewing sarcoma (ES) can occur months or years after initial remission, and salvage therapy for relapsed disease is usually ineffective. Thus, there is great need to develop biomarkers that can predict which patients are at risk for relapse so that therapy and post‐therapy evaluation can be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Volchenboum, Samuel L., Andrade, Jorge, Huang, Lei, Barkauskas, Donald A., Krailo, Mark, Womer, Richard B., Ranft, Andreas, Potratz, Jenny, Dirksen, Uta, Triche, Timothy J., Lawlor, Elizabeth R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457396/ https://www.ncbi.nlm.nih.gov/pubmed/26052443 http://dx.doi.org/10.1002/cjp2.9

Ejemplares similares

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group
por: Shulman, David S., et al.
Publicado: (2018)

Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group
por: Shulman, David S., et al.
Publicado: (2019)

Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma
por: Gerrand, Craig, et al.
Publicado: (2020)

The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling
por: Berning, Philipp, et al.
Publicado: (2018)

The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma
por: Berning, Philipp, et al.
Publicado: (2020)

Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children’s Oncology Group
por: Shukla, Neerav, et al.
Publicado: (2013)

A Decade in Banking Ewing Sarcoma: A Report from the Children’s Oncology Group
por: Borinstein, Scott C., et al.
Publicado: (2013)

Differentially Expressed miRNAs in Ewing Sarcoma Compared to Mesenchymal Stem Cells: Low miR-31 Expression with Effects on Proliferation and Invasion
por: Karnuth, Bianca, et al.
Publicado: (2014)

Secondary Malignancies after Ewing Sarcoma—Epidemiological and Clinical Analysis of an International Trial Registry
por: Kaiser, Isabelle, et al.
Publicado: (2022)

Dynamic prediction of overall survival: a retrospective analysis on 979 patients with Ewing sarcoma from the German registry
por: Liu, Chuchu, et al.
Publicado: (2020)

Clinical and Biochemical Function of Polymorphic NR0B1 GGAA-Microsatellites in Ewing Sarcoma: A Report from the Children's Oncology Group
por: Monument, Michael J., et al.
Publicado: (2014)

Localized Ewing sarcoma of the tibia
por: Kashima, Takeshi G, et al.
Publicado: (2013)

Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group Report
por: Marina, Neyssa, et al.
Publicado: (2015)

Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children’s Oncology Group
por: Shulman, David S., et al.
Publicado: (2022)

Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review
por: Haveman, Lianne M., et al.
Publicado: (2020)

Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours
por: Kelleher, Fergal C, et al.
Publicado: (2012)

CD133 expression in chemo-resistant Ewing sarcoma cells
por: Jiang, Xiaohua, et al.
Publicado: (2010)

Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma
por: Fuest, Sebastian, et al.
Publicado: (2022)

The First European Interdisciplinary Ewing Sarcoma Research Summit
por: Kovar, Heinrich, et al.
Publicado: (2012)

T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G
por: Spurny, Christian, et al.
Publicado: (2017)

Effect of Radiotherapy Dose on Outcome in Nonmetastatic Ewing Sarcoma
por: Kersting, Josephine, et al.
Publicado: (2023)

Ewing Sarcoma as Secondary Malignant Neoplasm—Epidemiological and Clinical Analysis of an International Trial Registry
por: Zöllner, Stefan K., et al.
Publicado: (2022)

FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma
por: Christensen, Laura, et al.
Publicado: (2013)

The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing Sarcoma
por: Haveman, Lianne M., et al.
Publicado: (2019)

Family history of cancer in children and adolescents with germ cell tumours: a report from the Children’s Oncology Group
por: Poynter, Jenny N, et al.
Publicado: (2018)

International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours – EURO EWING 2012 Protocol
por: Anderton, Jennifer, et al.
Publicado: (2020)

Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor
por: Knowles, Helen J, et al.
Publicado: (2010)

Ewing-like sarcoma bladder primary tumour: A case report and literature review
por: Nakdali Kassab, B., et al.
Publicado: (2022)

Non-gastrointestinal stromal tumours soft tissue sarcomas: an update
por: Matos, Gustavo Duarte Ramos, et al.
Publicado: (2019)

Characterization and Drug Resistance Patterns of Ewing's Sarcoma Family Tumor Cell Lines
por: May, William A., et al.
Publicado: (2013)

Impact of tumour rupture risk on the oncological rationale for the surgical treatment choice of gastrointestinal stromal tumours
por: Peparini, Nadia
Publicado: (2023)

Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery
por: Bosma, S. E., et al.
Publicado: (2019)

Proliferation Index: A Continuous Model to Predict Prognosis in Patients with Tumours of the Ewing's Sarcoma Family
por: Brownhill, Samantha, et al.
Publicado: (2014)

Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)
por: Oberlin, O, et al.
Publicado: (2001)

Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth
por: Vasileva, Elena, et al.
Publicado: (2022)

Tumour lysis syndrome in a patient with undifferentiated endometrial stromal sarcoma
por: Ahmed, Zeeshan, et al.
Publicado: (2019)

Prognostic impact of chromosomal aberrations in Ewing tumours
por: Hattinger, C M, et al.
Publicado: (2002)

Ewing's tumour, a report on 27 cases
por: Vohar, Vyankat G
Publicado: (2008)

Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis
por: Abudu, A, et al.
Publicado: (1999)

First children's solid tumour group workshop on Ewing's Sarcoma - June 30-July 1, 1989
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_tss3a8vakrguogahaqfoug0vu4